Evidence map›Paper›PMID 40230027›Full record

ArticleJournal of hepato-biliary-pancreatic sciences2025

The impact of the novel EUS scope and ultrasonographic system for diagnosis and therapy in patients with pancreatobiliary diseases (videos).

Hiroyuki Kojima, Takao Itoi, Atsushi Sofuni, Takayoshi Tsuchiya, Reina Tanaka, Ryosuke Tonozuka, Shuntaro Mukai, Kenjiro Yamamoto, Yukitoshi Matsunami, Hirohito Minami

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of hepato-biliary-pancreatic sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hiroyuki KojimaDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.ORCID https://orcid.org/0000-0001-6043-8379
Takao ItoiDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Atsushi SofuniDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Takayoshi TsuchiyaDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.ORCID https://orcid.org/0000-0002-2586-0635
Reina TanakaDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Ryosuke TonozukaDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.ORCID https://orcid.org/0000-0003-3999-2847
Shuntaro MukaiDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5737-620X
Kenjiro YamamotoDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.ORCID https://orcid.org/0000-0002-9507-2239
Yukitoshi MatsunamiDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Hirohito MinamiDepartment of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe evaluated the diagnostic and therapeutic capabilities of endoscopic ultrasonography (EUS) in pancreaticobiliary diseases. We aimed to validate the efficiency of detective flow imaging (DFI), shear wave elastography (SWE), and other advanced imaging techniques.

methodsWe used new EUS scopes (EG-740 UT and G-580UR) and the latest ultrasound equipment (ARIETTA 850) (Fujifilm Healthcare, Kanagawa, Japan). Diagnostic procedures were performed in 16 cases, including pancreatic cancer and intraductal papillary mucinous neoplasms, and therapeutic procedures in eight cases, involving complex biliary and pancreatic interventions. The utility of SWE in assessing tissue stiffness was quantified by measuring the shear wave velocity (SWV) in pancreatic cancer and autoimmune pancreatitis.

resultsWe found no significant difference in SWVs among different pancreatic conditions; however, significant variations were observed in the net percentage of effective SWV. Interventional EUS had a 100% technical and clinical success rate, demonstrating the efficacy of new imaging techniques and equipment in enhancing procedural safety and diagnostic accuracy.

conclusionsThe integration of advanced EUS imaging technologies, particularly DFI, contrast-enhanced EUS, and SWE, significantly enhances the diagnosis and treatment of pancreaticobiliary diseases.

Indexed as

Biliary Tract DiseasesEndosonographyPancreatic DiseasesPancreatic NeoplasmsAgedAged, 80 and overElasticity Imaging TechniquesEquipment DesignFemaleHumansMaleMiddle Agedautoimmune pancreatitisdetective flow imagingendoscopic ultrasonographypancreatic cancershear wave elastography

Identifiers

PMID40230027
PMCPMC12276461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.